GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » 5-Year EBITDA Growth Rate

U-Neuron Biomedical (ROCO:6973) 5-Year EBITDA Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical 5-Year EBITDA Growth Rate?

U-Neuron Biomedical's EBITDA per Share for the six months ended in Jun. 2024 was NT$-0.96.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of U-Neuron Biomedical's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, U-Neuron Biomedical's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's 5-Year EBITDA Growth Rate falls into.



U-Neuron Biomedical 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


U-Neuron Biomedical  (ROCO:6973) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


U-Neuron Biomedical 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical Headlines

No Headlines